| Autor: |
Ferreira Tomaz A; Postgraduate Program in Process Engineering, Federal University of Campina Grande, Campina Grande, PB 58429-900, Brazil. alecsandratomaz@hotmail.com., Sobral de Carvalho SM; Postgraduate Program in Materials Science and Engineering, Federal University of Campina Grande, Campina Grande, PB 58429-900, Brazil. sandram.carvalho@hotmail.com., Cardoso Barbosa R; Postgraduate Program in Materials Science and Engineering, Federal University of Campina Grande, Campina Grande, PB 58429-900, Brazil. rcbvet@gmail.com., L Silva SM; Department of Materials Engineering, Federal University of Campina Grande, Campina Grande, PB 58429-900, Brazil. suedina.silva@ufcg.edu.br., Sabino Gutierrez MA; B5IDA Research Group, Chemistry Department, Simon Bolivar University, Caracas 89000, Venezuela. msabino@usb.ve., B de Lima AG; Department of Mechanical Engineering, Federal University of Campina Grande, Campina Grande, PB 58429-900, Brazil. antonio.gilson@ufcg.edu.br., L Fook MV; Department of Materials Engineering, Federal University of Campina Grande, Campina Grande, PB 58429-900, Brazil. marcus.liafook@certbio.ufcg.edu.br. |
| Abstrakt: |
The aim of this paper was to prepare, by the freeze-drying method, ionically crosslinked chitosan membranes with different contents of pentasodium tripolyphosphate (TPP) and loaded with 1,4-naphthoquinone (NQ14) drug, in order to evaluate how the physical crosslinking affects NQ14 release from chitosan membranes for cancer therapy application. The membranes were characterized by Fourier transform infrared spectroscopy (FTIR), wide-angle X-ray diffraction (WAXD), scanning electron microscopy (SEM), swelling degree, and through in vitro drug release and cytotoxicity studies. According to the results, the molecular structure, porosity and hydrophilicity of the chitosan membranes were affected by TPP concentration and, consequently, the NQ14 drug release behavior from the membranes was also affected. The release of NQ14 from crosslinked chitosan membranes decreased when the cross-linker TPP quantity increased. Thus, depending on the TPP amount, the crosslinked chitosan membranes would be a potential delivery system to control the release of NQ14 for cancer therapy application. Lastly, the inhibitory potential of chitosan membranes ionically crosslinked with TPP and loaded with NQ14 against the B16F10 melanoma cell line was confirmed through in vitro cytotoxicity studies assessed via MTT assay. The anti-proliferative effect of prepared membranes was directly related to the amount of cross-linker and among all membranes prepared, such that one crosslinked with 0.3% of TPP may become a potential delivery system for releasing NQ14 drug for cancer therapy. |
